Vice President of Program Management & Leadership, Neuroscience Drug Development

New Haven, Connecticut /
Research & Development – Research & Development /
Full-time
/ Hybrid
Position Summary:
VP, Program Management, is a core member of development teams, partnering with line function team leaders to develop strategies, outline plans, and execute drug development programs from Phase III to NDA. The program manager is expected to provide thorough cross-functional project management leadership to project teams, ensuring alignment and execution of integrated cross-functional program strategy and operational plans. Position interacts with executive team on a frequent basis.  
Accountabilities
•Manage projects in any phase of development.
•Together with project team, develop project strategy and integrated project plans.
•Ensure alignment of project development plans with corporate strategy and operational plans.
•In partnership with project team develop and assess scenarios, options, and decision criteria.
•Drive decision making within the project team.
•Develop and maintain detailed project timelines.
•Work with project team to proactively identify and manage risks and develop mitigation strategies.
•Continually track project status and progress.
•Collaborate closely with project team and functional areas to drive project execution, delivering
•projects on-time, within scope, and within budget.
•Ensure clear and effective communication within and from the project team.
•Embed robust stakeholder management.
•Partnering with stakeholders ensure resources/budgets are planned and managed.
•Communicate project status/issues to senior management.
•Proactively identify and work to remove obstacles to drive business results.
•Maintain comprehensive project documentation.
•Develop and maintain high performing project teams.
•Assess project performance.

Required Education, Skills and Experience 
•MSc degree, PhD preferred.
•At least 15 years’ experience in pharmaceutical industry in roles associated with drug development, with at least 10 years’ experience in project management.
•Project Management Professional (PMP) certification preferred.

Desirable Education, Skills and Experience
•Must be able to work both independently and collaboratively in a fast-paced multi-disciplinary team, consisting of internal and external team members.
•Demonstrated experience building and managing multi-disciplinary teams.
•Excellent communication and interpersonal skills.
•Strong organizational skills, including attention to detail and multi-tasking skills
•Must be able to work both independently and collaboratively in a fast-paced multi-disciplinary team, consisting of internal and external team members.
•Demonstrated experience building and managing multi-disciplinary teams.
•Excellent communication and interpersonal skills.
•Strong organizational skills, including attention to detail and multi-tasking skills

Working Relationships
•Senior management and cross-functional team 

Work Environment
•Some travel is required. 







Your Path to Endless Opportunities

If you’re looking to push the envelope and join an innovative company where technology meets drug discovery and development and you’re enthusiastic, creative, with a passion for cutting-edge research, you should join our team! We are looking for highly motivated, passionate employees to help us drive technology solutions for discovering breakthrough treatments for our portfolio of oncology and neuroscience programs, as well as for our partners across major therapeutic areas.

About BioXcel Therapeutics, Inc.

BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The Company’s drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and proprietary machine learning algorithms to identify new therapeutic indices. The Company’s commercial product, IGALMI™ (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults. The safety and effectiveness of IGALMI has not been established beyond 24 hours from the first dose. BXCL501 is also being evaluated for the acute treatment of agitation associated with Alzheimer’s disease, and as an adjunctive treatment for major depressive disorder. The Company is also developing BXCL502 as a potential therapy for chronic agitation in dementia and, under its subsidiary OnkosXcel Therapeutics, BXCL701, an investigational, orally administered, systemic innate immunity activator for the treatment of aggressive forms of prostate cancer and advanced solid tumors that are refractory or treatment naïve to checkpoint inhibitors. For more information, please visit www.bioxceltherapeutics.com.   

EOE/M/F/V/SO
BioXcel Therapeutics is an Equal Opportunity Employer. All qualified candidates will receive consideration for employment without regard to race, color, religion, sex, national origin, disability, gender identity, sexual orientation or protected veteran status.